Teladoc Health (NYSE: TDOC) appoints Mark Anquillare to its board
Rhea-AI Filing Summary
Teladoc Health, Inc. increased its Board of Directors to ten members and appointed Mark V. Anquillare as an independent director effective August 3, 2026. He joins both the audit and compensation committees and has been designated an “audit committee financial expert” under SEC and New York Stock Exchange rules.
The company states there are no related-party arrangements or transactions requiring disclosure in connection with his appointment. Anquillare will receive the same indemnification protections and be eligible for the standard compensation programs for Teladoc Health’s non‑employee directors. A press release announcing his appointment was issued on August 3, 2026.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 5.02, 7.01, 9.01
3 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Board size: ten directors
Effective date of appointment: August 3, 2026
Exhibit 99.1 date: August 3, 2026
+1 more
4 metrics
Board size
ten directors
Number of Teladoc Health directors after the increase effective August 3, 2026
Effective date of appointment
August 3, 2026
Date Mark V. Anquillare was appointed to the Board of Directors
Exhibit 99.1 date
August 3, 2026
Date of Teladoc Health press release announcing Mark V. Anquillare’s board appointment
Board committees
2 committees
Audit committee and compensation committee on which Mark V. Anquillare will serve
Key Terms
audit committee financial expert, Regulation FD, non-executive Chairman, virtual care
4 terms
audit committee financial expert regulatory
"designated an “audit committee financial expert” under SEC and New York Stock Exchange rules"
A person on a company’s board who has deep knowledge of accounting, financial reporting and auditing, able to understand and question the books, controls and audit work like a trained mechanic inspecting an engine. Investors care because that expertise helps spot errors, weaknesses or misleading statements early, improving the likelihood that financial reports are accurate and reducing the risk of surprises that can hurt a company’s value.
Regulation FD regulatory
"Item 7.01 Regulation FD. On August 3, 2026, the Company issued a press release"
Regulation FD is a rule that prevents company insiders, like executives, from sharing important information with some people before others get it. It matters because it helps ensure all investors have equal access to key news, making the stock market fairer and reducing chances of insider trading.
non-executive Chairman other
"said Kenneth H. Paulus, non-executive Chairman of the Teladoc Health board"
A non-executive chairman leads a company's board of directors but does not run day-to-day operations or hold an executive management role; they focus on overseeing strategy, setting board agendas, and holding executives accountable. For investors, this role matters because a capable, independent chair can strengthen corporate governance, reduce management risk, and influence long-term strategy and leadership choices—like a team captain who watches the game and makes calls without playing on the field.
virtual care medical
"Teladoc Health (NYSE: TDOC), the global leader in virtual care"
Healthcare services delivered remotely using video calls, phone, secure messaging, or connected devices that track symptoms and vital signs — essentially a virtual doctor’s visit or digital check-in instead of an in-person appointment. Investors watch virtual care because it can change how quickly a provider or tech company reaches more customers, cuts or shifts operating costs, and alters reimbursement and competitive dynamics, much like online banking reshaped how people access financial services.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What change did Teladoc Health (TDOC) make to its board of directors?
Teladoc Health expanded its board to ten directors and appointed Mark V. Anquillare as a new independent director effective August 3, 2026. He will serve on both the audit committee and the compensation committee, adding financial and governance expertise to the board.
What roles will Mark V. Anquillare hold on Teladoc Health’s (TDOC) board?
Mark V. Anquillare will serve as an independent director on Teladoc Health’s board and sit on the audit and compensation committees. He has also been designated an “audit committee financial expert” under SEC and New York Stock Exchange rules, highlighting his financial oversight experience.
Is Mark V. Anquillare considered independent under NYSE rules for Teladoc Health (TDOC)?
Yes. Teladoc Health’s board determined that Mark V. Anquillare is an independent director under New York Stock Exchange listing standards. He is also classified as an audit committee financial expert, which qualifies him to provide enhanced oversight of the company’s financial reporting and controls.
Will Mark V. Anquillare receive the same compensation as other Teladoc Health (TDOC) non-employee directors?
Yes. Teladoc Health states that Mr. Anquillare will be eligible to participate in the same compensation arrangements and programs established for its non‑employee directors. He will also benefit from the standard director indemnification agreement used since October 2020.
How did Teladoc Health (TDOC) communicate Mark V. Anquillare’s appointment to investors?
Teladoc Health issued a press release dated August 3, 2026 announcing Mark V. Anquillare’s appointment to its board. That release, identified as Exhibit 99.1, provides additional background on his prior roles and explains the committees on which he will serve.